openPR Logo
Press release

The Global Sepsis Diagnostics Market Estimated to Reap $900.7 Million in Revenue by 2028

11-22-2022 05:09 AM CET | Health & Medicine

Press release from: Triton Market Research

Sepsis Diagnostics Market

Sepsis Diagnostics Market

A recent study by Triton Market Research titled 'Global Sepsis Diagnostics Market' entails the Global Analysis and Forecasts by Technology (Microbiology, Immunoassay, Molecular Diagnostics, Other Technologies), Diagnostic Method (Automated Diagnostics, Conventional Diagnostics), Pathogen (Fungal Sepsis, Gram-Positive and Gram-Negative Bacterial Sepsis, Other Pathogens), Testing Type (Point-of-Care Testing, Laboratory Testing), Product (Instruments, Assay Kits & Reagents, Blood Culture Media), and by Geography (North America, Latin America, Asia-Pacific, Middle East and Africa, Europe).

Request Free Sample of the Global Sepsis Diagnostics Market Report @ https://www.tritonmarketresearch.com/reports/sepsis-diagnostics-market#request-free-sample

Triton's report predicts the global sepsis diagnostics market to develop at a CAGR of 8.18% during the projected period of 2021-2028. It is further evaluated to reap revenue worth $900.7 million by 2028.

Sepsis is a serious disease emerging from the body's reaction to pathogenic microorganisms in the blood. The diagnostics method to treat sepsis includes automated and conventional diagnostics.

Sepsis is considered a life-threatening condition caused by the body's response to an infection, leading to tissue damage, organ failure, and death.

Hence, the increasing prevalence of sepsis is driving the progression of the sepsis diagnostics market across the world. However, the high cost of a diagnostic instrument can significantly reduce operations profitability for laboratories or other organizations. Hence, the high cost associated with the instrument weighs down the growth of the sepsis diagnostics market globally.

The market for sepsis diagnostics is sectioned into technology, diagnostic method, pathogen, testing type, and product. The technology section is divided into microbiology, immunoassay, molecular diagnostics, and other technologies. In terms of diagnostic method, the market is bifurcated into automated diagnostics and conventional diagnostics. The pathogen segment is divided into fungal sepsis, gram-positive and gram-negative bacterial sepsis, and other pathogens. The testing type is branched into point-of-care testing and laboratory testing. Lastly, the product section is categorized into instruments, assay kits & reagents, and blood culture media.

The Asia-Pacific is likely to become the fastest-growing market for sepsis diagnostics over the registered period 2021-2028. The studied market is experiencing lucrative growth owing to multiple factors, such as rapid economic development and advancement in the healthcare system. Moreover, the demand for sepsis diagnostics is likely to be higher across emerging nations due to the rise in mortality rate associated with sepsis disease.

Along with this, the growing awareness about sepsis diagnosis and treatment is estimated to help counter the disease's severe effects, thereby driving the sepsis diagnostics market's growth.

T2 Biosystems Inc, Becton Dickinson and Company (CR Bard), EKF Diagnostics, Biomerieux SA, Response Biomedical Corporation, Cytosorbents, F Hoffmann-La Roche, Thermo Fisher Scientific Inc, Abbott Laboratories, Luminex Corporation, Bruker Corporation, Danaher Corporation, and Immunexpress Inc are prominent enterprises engaged in the sepsis diagnostics market.

Purchase this Report @ https://www.tritonmarketresearch.com/reports/sepsis-diagnostics-market#purchase-option

Question & Answer: Sepsis Diagnostics Market

Question 1: What factor is driving the progression of the sepsis diagnostics market?
Answer: Sepsis is considered a life-threatening condition caused by the body's response to an infection, leading to tissue damage, organ failure, and death. Hence, the increasing prevalence of sepsis is driving the progression of the sepsis diagnostics market across the world.

Question 2: What fact weighs down the growth of the sepsis diagnostics market globally?
Answer: The high cost of a diagnostic instrument can significantly reduce operations profitability for laboratories or other organizations. Hence, the high cost associated with the instrument weighs down the growth of the sepsis diagnostics market globally.

Question 3: Which region is is likely to become the fastest-growing in the sepsis diagnostics market?
Answer: The Asia-Pacific is likely to become the fastest-growing market for sepsis diagnostics over the registered period 2021-2028. The studied market is experiencing lucrative growth owing to multiple factors, such as rapid economic development and advancement in the healthcare system. Moreover, the demand for sepsis diagnostics is likely to be higher across emerging nations due to the rise in mortality rate associated with sepsis disease. Along with this, the growing awareness about sepsis diagnosis and treatment is estimated to help counter the disease's severe effects, thereby driving the sepsis diagnostics market's growth.

Question 4: Which are the prominent enterprises engaged in the sepsis diagnostics market?
Answer: T2 Biosystems Inc, Becton Dickinson and Company (CR Bard), EKF Diagnostics, Biomerieux SA, Response Biomedical Corporation, Cytosorbents, F Hoffmann-La Roche, Thermo Fisher Scientific Inc, Abbott Laboratories, Luminex Corporation, Bruker Corporation, Danaher Corporation, and Immunexpress Inc are prominent enterprises engaged in the sepsis diagnostics market.

Related Report:
Global Surgical Site Infection Control Market - https://www.tritonmarketresearch.com/reports/surgical-site-infection-control-market#report-overview

The global surgical site infection control market is evaluated to display growth in its revenue during 2021-2028 at a CAGR of 5.95%. It is projected to acquire revenue worth $6969.5 by 2028.

Surgical site infection emerges post-surgery on the body part where the surgery was directed. These infections can either be incisional or organ-related.

Factors such as the rising aging population, along with the enactment of better infection prevention practices, are driving the growth of the studied market worldwide. Additionally, the rise in surgical procedures and increased healthcare-related infections are generating new opportunities for the surgical site infection control market.

However, the lack of infection control programs and increased outpatient procedures are obstructing the studied market's expansion.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Sepsis Diagnostics Market Estimated to Reap $900.7 Million in Revenue by 2028 here

News-ID: 2815392 • Views:

More Releases from Triton Market Research

The Global Hospital Gowns Market is Growing Due to Disease Prevalence
The Global Hospital Gowns Market is Growing Due to Disease Prevalence
According to Triton's research analysis, the hospital gowns market was valued at $4428.34 million in 2022, and is expected to expand at a CAGR of 11.83% from 2023 to 2030. A study by Triton Market Research titled 'Global Hospital Gowns Market' includes the Global Analysis and Forecasts by Type (Patient Gowns, Surgical Gowns, Non-Surgical Gowns), by Protection Level (Minimal, Low, Moderate, High), by Usability (Reusable Gowns, Disposable Gowns), by End-user (Hospitals,
Forecasts and Market Development for Flue Gas Desulfurization
Forecasts and Market Development for Flue Gas Desulfurization
As per Triton's research report, the global market for flue gas desulphurization generated a $21754.15 million revenue in 2022 and is expected to rise with a CAGR of 4.93% over the forecasting years 2023-2030. A recent study by Triton Market Research titled Global Flue Gas Desulphurization Market includes the Global Analysis and Forecasts by Application (Iron and Steel, Power Generation, Cement Manufacturing, Chemicals, Other Applications), Technology (Spray Dry FGD Systems, Wet
Global Defoamers Market | Scope & Usage Forecast for 2023-2030
Global Defoamers Market | Scope & Usage Forecast for 2023-2030
According to Triton's research report, the global defoamers market generated $3484.41 million in 2022 and is expected to rise with a CAGR of 4.77% in revenue over the forecasting years 2023-2030. A recent study by Triton Market Research titled Global Defoamers Market includes the Global Analysis and Forecasts by Application (Water Treatment, Agrochemicals, Food & Beverages, Coatings, Pulp & Paper, Oil & Gas, Other Applications), Type (Silicone-Based Defoamers, Oil-Based, Water-Based, Other
Growth Projections for the Forklift Truck Market, 2023-2030
Growth Projections for the Forklift Truck Market, 2023-2030
Triton's report estimates the global forklift truck market reached $68,393.39 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 8.08% by 2030. A recent study by Triton Market Research titled Global Forklift Truck Market includes the Global Analysis and Forecasts by Power Source (Electric Motor, Internal Combustion Engine), End-user (Logistics, Automotive, Manufacturing, Retail & Wholesale, Food Industry, Other End-users), Class (Class 1, Class 2,

All 5 Releases


More Releases for Diagnostic

Tenet Diagnostic: Reshaping the Diagnostic Industry in India
Tenet Diagnostic was incorporated in 2018 with an aim to establish high-quality diagnostics laboratories across India. The company caters to both B2B and B2C. They have seven different verticals namely: End Customer (B2C), Lab to Lab Test Outsourcing, Corporates and Institutions, large management (Hospitals, Medical Colleges, and other healthcare institutions), Clinical Trials, Home Sample Collection, and Government PPP Projects. Tenet Diagnostics got its NABL certification in the fastest time and is
Global Tissue Diagnostic Market 2020 Business Strategies – Roche Diagnostic, A …
The Zion Market Research added a new report “Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017
Diagnostic Imaging Services Market 2019 Analyzed by Top Key Players PH3 Healthca …
Big Market Research has added a report, titled, "Diagnostic Imaging Services" The report not only provides a comprehensive analysis of market overview and dynamics for the historical period, 2019-2026, but also offers global and regional forecasts on market value, volume production, and consumption during the future period, 2019-2026. The report also analyzes the key market players, especially the distributors, along with the industrial chain structure. The evolution of market trends
POC Cardiovascular Diagnostic Market Report 2018: Segmentation by Product (Diagn …
Global POC Cardiovascular Diagnostic market research report provides company profile for F. Hoffmann-La Roche, Siemens, Abbott, Biomerieux, Danaher and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on
Cervical Dysplasia Diagnostic Market - by Diagnostic, and End Users
Cervical infection is major risk factor for progression of HPV. Currently, conventional Pap smear test or HPV test are the only test available for screening cervical infection, which in turn propels the demand for development of DNA-based molecular testing to detect human papillomavirus for diagnosis of cervical cancer. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV
Diagnostic Imaging Services Market Trending Technologies and Company Overview 20 …
Diagnostic Imaging Services market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the